|
1
|
Boyle P and Levin B: World Cancer Report
2008. IARC; Lyon, France: 2008
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J and
Ward:
|
|
3
|
Klimczak A, Bitner J and Szemraj J: Genes
responsible for etiopathogenesis in esophageal squamous cell
carcinoma. Postepy Biochem. 57:33–40. 2011.(In Polish). PubMed/NCBI
|
|
4
|
Lam AK: Molecular biology of esophageal
squamous cell carcinoma. Crit Rev Oncol Hematol. 33:71–90. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Klimczak A, Kuropatwa A, Lewkowski J and
Szemraj J: Synthesis of new N-arylamino (2-furyl) methylphosphonic
acid diesters and in vitro evaluation of their cytotoxicity against
esophageal cancer cells. Med Chem Res. 22:852–860. 2013. View Article : Google Scholar
|
|
6
|
Law S and Wong J: Therapeutic options for
esophageal cancer. J Gastroenterol Hepatol. 19:4–12. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hartwig W, Strobel O, Schneider L, Hackert
T, Hesse C, Büchler MW and Werner J: Fundus rotation gastroplasty
vs. Kirschner-Akiyama gastric tube in esophageal resection:
Comparison of perioperative and long-term results. World J Surg.
32:1695–1702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ordu AD, Nieder C, Geinitz H, Kup PG,
Deymann LF, Scherer V, Combs SE and Fakhrian K: Radio(chemo)therapy
for locally advanced squamous cell carcinoma of the esophagus:
Long-term outcome. Strahlenther Onkol. 191:153–160. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rabenstein T: Palliative endoscopic
therapy of esophageal cancer. Viszeralmedizin. 31:354–359. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thorsen SB, Obad S, Jensen NF, Stenvang J
and Kauppinen S: The therapeutic potential of microRNAs in cancer.
Cancer J. 18:275–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson KE and Wilgus TA: Vascular
Endothelial Growth Factor and Angiogenesis in the Regulation of
Cutaneous Wound Repair. Adv Wound Care (New Rochelle). 3:647–661.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
47:275–292. 2011. View Article : Google Scholar
|
|
18
|
Bal J: Biologia Molekularna W Medycynie.
Wydawnictwo Naukowe PWN; Warszawa: 2011, (In Polish).
|
|
19
|
Qiagen, . RT2 Profiler PCR Array Handbook.
Qiagen, USA: pp. 27–48. 2011
|
|
20
|
Kajiwara T, Hiasa Y, Nishina T, Matsumoto
T, Hori S, Nadano S, Iguchi H, Takeji S, Tsubouchi E, Ikeda Y, et
al: Maximum standardized uptake value in 18F-fluoro-2-deoxyglucose
positron emission tomography is associated with advanced tumor
factors in esophageal cancer. Mol Clin Oncol. 2:313–321.
2014.PubMed/NCBI
|
|
21
|
Kameyama H, Udagawa O, Hoshi T, Toukairin
Y, Arai T and Nogami M: The mRNA expressions and
immunohistochemistry of factors involved in angiogenesis and
lymphangiogenesis in the early stage of rat skin incision wounds.
Leg Med (Tokyo). 17:255–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Biosystems A: Megaplex™ Pools For microRNA
Expression Analysis. Biosystems A; USA: pp. 15–22. 2010
|
|
23
|
Akagi I, Miyashita M, Ishibashi O, Mishima
T, Kikuchi K, Makino H, Nomura T, Hagiwara N, Uchida E and Takizawa
T: Relationship between altered expression levels of MIR21, MIR143,
MIR145, and MIR205 and clinicopathologic features of esophageal
squamous cell carcinoma. Dis Esophagus. 24:523–530. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260; discussion 260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Giovannetti E, Funel N, Peters GJ, Del
Chiaro M, Erozenci LA, Vasile E, Leon LG, Pollina LE, Groen A and
Falcone A: MicroRNA-21 in pancreatic cancer: Correlation with
clinical outcome and pharmacologic aspects underlying its role in
the modulation of gemcitabine activity. Cancer Res. 70:4528–4538.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vergoulis T, Vlachos IS, Alexiou P,
Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N,
Dalamagas T and Hatzigeorgiou AG: TarBase 6.0: Capturing the
exponential growth of miRNA targets with experimental support.
Nucleic Acids Res. 40:D222–D229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Houldsworth J, Cordon-Cardo C, Ladanyi M,
Kelsen DP and Chaganti RS: Gene amplification in gastric and
esophageal adenocarcinomas. Cancer Res. 50:6417–6422.
1990.PubMed/NCBI
|
|
28
|
Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y and
Chen KN: Matrix metalloproteinases expression correlates with
survival in patients with esophageal squamous cell carcinoma. Am J
Gastroenterol. 100:1835–1843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong FH, Hu CP, Chen SC, Yu YT and Chang
C: Absence of genomes of DNA tumor viruses and expression of
oncogenes and growth factors in two esophageal carcinoma cell lines
of Chinese origin. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za
Zhi. 25:59–68. 1992.PubMed/NCBI
|
|
30
|
Aoki K, Nishino N, Baba S, Urano T and
Takada A: Postoperative changes in plasma tissue-type plasminogen
activator and type 1 plasminogen activator inhibitor. Surg Today.
24:1039–1043. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamano R, Miyata H, Yamasaki M, Kurokawa
Y, Hara J, Moon JH, Nakajima K, Takiguchi S, Fujiwara Y, Mori M and
Doki Y: Overexpression of miR-200c induces chemoresistance in
esophageal cancers mediated through activation of the Akt signaling
pathway. Clin Cancer Res. 17:3029–3038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo Y, Chen Z, Zhang L, Zhou F, Shi S,
Feng X, Li B, Meng X, Ma X, Luo M, et al: Distinctive microRNA
profiles relating to patient survival in esophageal squamous cell
carcinoma. Cancer Res. 68:26–33. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Snel B, Lehmann G, Bork P and Huynen MA:
STRING: A web-server to retrieve and display the repeatedly
occurring neighbourhood of a gene. Nucleic Acids Res. 28:3442–3444.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wagner M, Kleeff J, Friess H, Buchler MW
and Korc M: Enhanced expression of the type II transforming growth
factor-beta receptor is associated with decreased survival in human
pancreatic cancer. Pancreas. 19:370–376. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pidgeon GP, Allott E, Donohoe C, Cathcart
M, McGarrigle S, Cummins R, Kay E and Reynolds J: Adipose tissue
upregulates MMP9 expression in oesophageal cancer promoting
invasion and migration in vitro and correlates with obesity status
and poor differentiation in vivo. Cancer Res. 71:(Suppl): abstract
1556. 2011. View Article : Google Scholar
|
